DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 17,917 Value ($000) $365 Avg Close $25.60 Range $19.93 - $33.33

Q3 2024

Shares 11,161 Value ($000) $325 Avg Close $24.79 Range $19.74 - $32.13

Q2 2024

Shares 29,357 Value ($000) $682 Avg Close $19.20 Range $14.56 - $23.87

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	17,917	$365	$25.60	$19.93 - $33.33
Q3 2024	11,161	$325	$24.79	$19.74 - $32.13
Q2 2024	29,357	$682	$19.20	$14.56 - $23.87